Abstract:Glioma is the most frequent tumor in central nervous system (CNS), constituting about 30% of CNS tumors and 80% of malignant brain tumors. The current standard strategy for glioma treatment is surgery plus adjuvant chemotherapy and concurrent radiotherapy. However, the prognosis of glioma is still poor. It has been proved that the existence of glioma stem cells and the timely repair of DNA damages are the main causes of treatment failure. Skp2 (S-phase kinase associated protein-2), a member of F-box proteins, forms the Skp2 SCF complex with Skp1, Cullin-1, and Rbx1, serves as one of the important E3-ligases in the process of ubiquitination, and is responsible for substrate recognition. Skp2 is overexpressed in a variety of human cancers and promotes cancer progression by inducing p27 degradation. Importantly, Skp2 deficiency profoundly restricts cancer progression in multiple genetic mouse tumor models. Our group has demonstrated that Skp2 is involved in the regulation of pool size and self-renewal ability of hematopoietic stem cells, as well as breast cancer stem cells and nasopharyngeal carcinoma stem cell-like cells. However, the exact role of Skp2 in the regulation of glioma stem cells and DNA damage repair in glioma has not been elucidated yet. We proposed that targeting Skp2 could promote radio- and chemotherapy sensitivity through suppressing function of glioma stem cells. We first detected the expression of SKP2 in glioma tumor tissues and found that SKP2 was highly expressed in glioma and related to the prognosis of glioma patients. We also adopted gene knockdown methods and inhibitor pretreatment with small molecules in order to suppress the level of Skp2, and then checked the sphere formation and self-renewal ability of glioma stem cell upon radio/chemo treatments. In this way we evaluated the role of Skp2 in repressing the glioma cell proliferation and subsequently triggering apoptosis. Our project will clarify the novel mechanisms about how Skp2 is involved in the glioma radio- and chemotherapy resistance, which will provide a potential target to improve the radio/chemo therapeutic effect through targeting one single target. Citation Format: Jing Wang, Hong-Kai Su, Zhong-Ping Chen, Yue Qu, Hai-Ping Cai. Investigation of targeting SKP2 to improve the treatment response in glioma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 1913.

The Association Between Salt-inducible Kinase 2 (SIK2) and Gamma Isoform of the Regulatory Subunit B55 of PP2A (b55gamma) Contributes to the Survival of Glioma Cells under Glucose Depletion Through Inhibiting the Phosphorylation of S6K

P90 Ribosomal S6 Kinase Confers Cancer Cell Survival by Mediating Checkpoint Kinase 1 Degradation in Response to Glucose Stress

PSMC2/E2F1 Axis Promotes the Development and Progression of Glioma

Glucose regulates the HMGB1 signaling pathway through SIRT1 in glioma

Over Expression of PPP2R2C Inhibits Human Glioma Cells Growth Through the Suppression of Mtor Pathway

SIK2 Promotes Reprogramming of Glucose Metabolism Through PI3K/AKT/HIF-1α Pathway and Drp1-mediated Mitochondrial Fission in Ovarian Cancer.

The role of SPI1/VSIG4/THBS1 on glioblastoma progression through modulation of the PI3K/AKT pathway

Sirt3 enhances glioma cell viability by stabilizing Ku70-BAX interaction

Shuttling SLC2A4RG is Regulated by 14-3-3θ to Modulate Cell Survival Via Caspase-3 and Caspase-6 in Human Glioma

Abstract 1913: Investigation of Targeting SKP2 to Improve the Treatment Response in Glioma

SAE1 Promotes Human Glioma Progression Through Activating AKT SUMOylation-mediated Signaling Pathways

Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF- κ B /IL-6/STAT3 and JNK/PTX3 pathways

Aerobic Glycolysis Promotes Tumor Immune Evasion by Hexokinase2-Mediated Phosphorylation of IκBα.

GSK-3 beta regulates tumor growth and angiogenesis in human glioma cells

Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-B/IL-6/STAT3 and JNK/PTX3 pathways

IGF2BP2 modulates autophagy and serves as a prognostic marker in glioma

Abstract 3079: AMPK-HIF-1α signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth

Enhanced radiosensitization of human glioblastoma multiforme cells with phosphorylated peptides derived from Gli2.

Skp2 Modulates Proliferation, Senescence and Tumorigenesis of Glioma

G Protein Inhibitory Α Subunit 2 is a Molecular Oncotarget of Human Glioma

Shuttling SLC2A4RG is Regulated by 14-3-3θ¸ to Modulate Cell Survival Via Caspase-3 and Caspase-6 in Human Glioma